Features of the treatment of bronchial asthma in children with overweight and obesity

O.P. Volosovets, S.P. Kryvopustov, A.V. Kupkina

Abstract


The article considers the questions of the treatment of bronchial asthma (BA) in children with overweight and obesity. The basic medication and non-medication approaches to the treatment of BA in children with overweight and obesity are described. The attention is focused on the advantages of using antileukotriene drugs in the basic treatment of BA in these patients.

Keywords


bronchial asthma; obesity; children

References


Avdeev SN, Aisanov ZR, Arkhipov VV et al. Agreed recommendations on the justification of the choice of treatment of asthma and chronic obstructive pulmonary disease based on the phenotype of the disease and the role of small airways. Prakticheskaya pulmonologiya. 2013;2:15-26. (in Russian).

Aleshina AI. Features of the application of medical physical training for children with asthma. Pedahohika, psykholohiya ta medyko-biolohichni problemy fizychnoho vykhovannya i sportu. 2012;6:12-15. (in Ukrainian).

Astaf’eva NH, Hamova YV, Udovychenko EN, Perfylova YA. Obesity and asthma. Lechashchyy vrach. 2014;5:100-106. (in Russian).

Zalessky VN, Velikaya NV, Omelchuk ST. Effect of probiotics on inflammatory responses and other risk factors for cardiovascular diseases. Ukrainsky medichny chasopis. 2014;6(104):49-56. (in Russian).

Kmyta VV, Orlovskiy VF. The effectiveness of asthmatreatment depending on the genotype of the gene polymorphism at bcl1 glucocorticoid receptor and body weight. Astma ta alerhiia. 2015;1:23-26. (in Ukrainian).

Kramarska NV. Features etiology, pathogenesis, clinical course and treatment approaches for severe asthma. Astma ta alerhiia. 2012;3:51-56. (in Ukrainian).

Mizernitskiy YuL. The clinical significance of antileukotriene drugs in the modern treatment of asthma in children. Effektivnaya farmakoterapiya. 2014;21:16-18. (in Russian).

Mitskevich SE. Place antileukotriene drugs in the treatment of bronchial asthma in children. Vestnik Chelyabinskogo gosudarstvennogo universiteta. 2014;4(333):165-168. (in Russian).

MON Ukraine from 08.10.2013 N 868 "On approval and introduction of medical and technological documents for standardization of care in asthma". (in Ukrainian).

MON Ukraine from 27.04.06 N 254 "On approving the protocols of care for children on a specialty" Children’s endocrinology". (in Ukrainian).

Pertseva TA, Nud’ha NP. Asthma and obesity: what is the relationship? Ukrayins’kyy pul’monolohichnyy zhurnal. 2011;1:61-64. (in Russian).

Pobedennaya GP, Yartsev SV. The question of comorbid diseases: asthma and obesity. Astma ta alerhiia. 2014;2:54-61. (in Russian).

Popadynets IR, Yatsyshyn RI. Clinical efficacy of quercetin in patients with concomitant asthma hastroezofahelnoyu reflux disease. Halytskyi likars’kyi visnyk. 2013;20(2):91-94. (in Ukrainian).

Pristupa LN. Efficiency polyoxidonium in patients with bronchial asthma in combination with visceral obesity and metabolic syndrome. Bukovynskyi medychnyi visnyk. 2006;10(1):59-61. (in Ukrainian).

Prystupa LN, Fadyeyeva HA. Bronkhial’na astma ta metabolichnyy syndrom [Bronchial asthma and metabolic syndrome]. Sumy: Sums’kyy derzhavnyy universytet; 2014. 239p. (in Ukrainian).

Radchenko OM, Slaba OR. The phenotype of asthma with obesity. Astma ta alerhiya. 2014;2:19-21. (in Ukrainian).

Senatorova GS, Chaychenko TV, Telnov LG, Lutay TV. The effectiveness of basic treatment of obesity in adolescents: Challenges. Svit medytsyny ta biolohii. 2012;2:65-71. (in Russian).

Tkach SM, Tymoshenko OS, Dorofeieva АА. The role of intestinal microbiota in obesity and insulin resistance. Klinichna endokrynolohiia ta endokrynna khirurhiia. 2016;1(53):7-16. (in Ukrainian).

Scherbakova MYu, Poryadina GI, Kovaleva EA. Obesity in childhood. Eksperimentalnaya i klinicheskaya gastroenterologiya. 2010;7:74-83. (in Russian).

Adeniyi FB, Young T. Weight loss interventions for chronic asthma. Cochrane Database Syst Rev. 2012 Jul 11;7:CD009339. doi: 10.1002/14651858.CD009339.

Juel CTB, Ali Z, Nilas L, Ulrik CS. Asthma and obesity: does weight loss improve asthma control? a systematic review. J Asthma Allergy. 2012;5:21-26. doi: 10.2147/JAA.S32232.

Fessler MB, Jaramillo R, Crockett PW et al. Relationship of serum cholesterol levels to atopy in the US population. Allergy. 2010;65:859-864.

Global Initiative for Asthma (GINA). Pocket guide for asthma management and prevention (for Adults and Children Older than 5 Years). Available from: http://ginasthma.org/wp-content/uploads/2016/01/GINA_Pocket_2015.pdf. Accessed: 2015.

Hakala K, Stenius-Aarniala K, Sovijarvi A. Effects of weight loss on Peak Flow Variability, Airway obstruction and lung volumes in obese patients with asthma. Chest. 2000;118:553-557.

Hartert TV, Peebles RS. Dietary antioxidants and adult asthma. Curr Opin Allergy Clin Immunol. 2001;1(5):421-429. PMID: 11964722.

Kazaks AG, Uriu-Adams JY, Albertson TE, Shenoy SF, Stern JS. Effect of oral magnesium supplementation on measures of airway resistance and subjective assessment of asthma control and quality of life in men and women with mild to moderate asthma: a randomized placebo controlled trial. J Asthma. 2010 Feb;47(1):83-92. doi: 10.3109/02770900903331127.

Kobyliak N, Conte C, Cammarota G, et al. Probiotics in prevention and treatment of obesity: a critical view. Nutrition & Metabolism. 2016;13:14. doi: 10.1186/s12986-016-0067-0.

Lang JE, Hossain J, Lima JJ. Overweight children report qualitatively distinct asthma symptoms: Analysis of validated symptom measures. Journal of Allergy and Clinical Immunology. 2015;135(4):886-893. doi: 10.1016/j.jaci.2014.08.029.

Nagakura T, Matsuda S, Shichijyo K, Sugimoto H, Hata K. Dietary supplementation with fish oil rich in omega-3 polyunaturated fatty acids in children with bronchial asthma. Eur Respir J. 2000;16:861-865. PMID: 11153584.

Novosad S, Khan S, Wolfe B, Khan A. Role of obesity in asthma control, the obesity-asthma phenotype. J Allergy. 2013;2013:ID538642. doi: 10.1155/2013/538642.

Peters-Golden M, Swern A, Bird SS, Hustad CM, Grant E, Edelman JM. Influence of body mass index on the response to asthma controller agents. Eur Respir J. 2006;27:495-503. doi: 10.1183/09031936.06.00077205.

Hasegawa K, Tsugawa Y, Chang Y, Camargo CA. Risk of an asthma exacerbation after bariatric surgery in adults. J Allergy Clin Immunol. 2015;136(2):288-94. doi: 10.1016/j.jaci.2014.12.1931.

Sanchez M, Panahi S, Tremblay A. Childhood Obesity: A Role for Gut Microbiota? Int J Environ Res Public Health. 2015;12:162-175. doi: 10.3390/ijerph120100162.

Silva ST, Santos CA, Bressan J. Intestinal microbiota; relevance to obesity and modulation by prebiotics and probiotics. Nutr Hosp. 2013;28(4):1039-1048. doi: 10.3305/nh.2013.28.4.6525.

Shore SA. Obesity and asthma: location, location, location. Eur Respir J. 2013;41(2):253-254. doi: 10.1183/09031936.00128812.

Stenius-Aarniala B, Poussa T, Kvarnström J, Grönlund EL, Ylikahri M, Mustajoki P. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ. 2000;320:827-832.

Sutherland ER, Camargo CA, Busse WW, et al. Comparative effect of body mass index on response to asthma controller therapy. Allergy and Asthma Proceedings. 2010;31(1):20-25. doi: 10.2500/aap.2010.31.3307.

Zohrabian A. Clinical and economic considerations of antiobesity treatment: a review of orlistat. Gastroenterology. 2015;3(57):85-93.




DOI: https://doi.org/10.22141/2224-0551.12.1.2017.95020

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 CHILD`S HEALTH

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© Publishing House Zaslavsky, 1997-2017

 

 Яндекс.МетрикаSeo анализ сайта Рейтинг@Mail.ru